The Antihypertensive Effect and Tolerability of Candesartan Cilexetil, a New Generation Angiotensin II Antagonist, in Comparison with Losartan

By ANDERSSON OVE K.   NELDAM STEEN  

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability

By ELMFELDT D.   GEORGE M.   HÜBNER R.   OLOFSSON B.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 54-54

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Candesartan Cilexetil in Special Patient Groups

By TRENKWALDER PETER  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 27-30

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, 16 mg, Provides a Greater Antihypertensive Effect than Losartan, 50 mg, in Patients with Mild to Moderate Hypertension

By ANDERSSON O. K.   NELDAM S.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 55-55

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of a Combination Tablet of Candesartan Cilexetil and Hydrochlorothiazide in Insufficiently Controlled Primary Hypertension - Comparison with a Combination of Losartan and Hydrochlorothiazide

By ÖHMAN K. PETER   MILON HUGUES   VALNES KOLBJØRN  

Blood Pressure, Vol. 9, Iss. 4, 2000-09 ,pp. : 214-220

Informa Healthcare

Access to resources Recommend Favorite